Bioanalytical method validation using LC-MS/MS
commonly used technique for sample preparation to reduce both time and labor in bioanalysis. Further, this presentation also discusses about the matrix effect in LC-MS/MS analysis
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
commonly used technique for sample preparation to reduce both time and labor in bioanalysis. Further, this presentation also discusses about the matrix effect in LC-MS/MS analysis
mass spectrometer (MS) with SFC can widen the scope of application of SFC to bioanalysis. Therefore, we have tried to apply SFC/MS to a metabolic profiling. We developed
Generally, monitoring interactions of nucleic acids by fluorescence is a convenient method in modern bioanalysis and can be performed under native conditions without additional equipment or procedures. Currently…
Whenever biosimilars are discussed, a common remark is that many blockbuster drugs
Clinicians in Europe continue to be reluctant to use biosimilar recombinant growth
In February 2012, the FDA issued guidance documents for the development of
The cell physiology in human eukaryotic cells so far explained assuming that
Last year, the global market for biological products exceeded $125 billion, accounting
Biosimilar is gaining great traction in the world as it offers expanded
The current draft guidance from the FDA, "Scientific Considerations in Demonstrating Biosimilarity
This presentation will provide an overview of litigation under the Biologics Price
It is well recognized that most licensed biologic products are covered by
Cancer is a debilitating disease affecting millions of people daily. Over the
Many companies have recently entered the biosimilar space. After the initial excitement
The usefulness and depth of a biosimilar to forward a program can
Biosimilar Act, passed in 2007 under 351(k), states that a biosimilar
Recently, the expiration of patents for a number of blockbuster biologics in
Any manufacturer seeking to develop and market a biosimilar product requires comprehensive
With the Biologics Price Competition and Innovation Act of 2009 (?Biosimilars Act
The relevance of immunogenicity in preclinical trials will be discussed as a
Disease modifying therapies (DMT) for multiple sclerosis (MS) are still very expensive
Activated Protein C (APC) is a naturally occurring human protease that has
Section 271(e)(1) of United States Code Title 35 provides a
The term ?biosimilar? refers to products marketed after expiration of patents and
We previously reported the existence of an overly abundant alternatively spliced form
For authors and organisers
Find the right journal for your paper and submit your manuscript.